As Bayer AG girds for two more trials over its Roundup weed killer, lawyers for consumers are angling to build on their first three courtroom victories that resulted in damages awards totaling $191 million.
The question for Bayer is, what can it do differently this time?
The German drug and chemical giant, which acquired Roundup maker Monsanto Co. in 2018, is trying to reverse the momentum of a litigation storm that has generated tens of thousands of cases alleging exposure to the herbicide causes cancer.
Read More: Bayer Is Said to Discuss $10 Billion Roundup Settlement
While a court-appointed mediator ...
